• Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 1: EWSR1 exon 8 fused to ATF1 exon 4 (PubMed=12021921; PubMed=15150091).
  

PubMed=11004677; DOI=10.1002/1097-0215(20001015)88:2<252::AID-IJC17>3.0.CO;2-U
van Valen F., Fulda S., Truckenbrod B., Eckervogt V., Sonnemann J., Hillmann A., Rodl R., Hoffmann C., Winkelmann W., Schafer L., Dockhorn-Dworniczak B., Wessel T., Boos J., Debatin K.-M., Jurgens H.
Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL).
Int. J. Cancer 88:252-259(2000)

PubMed=12021921; DOI=10.1007/s00428-001-0558-9
Schaefer K.-L., Wai D.H., Poremba C., Korsching E., van Valen F., Ozaki T., Boecker W., Dockhorn-Dworniczak B.
Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays.
Virchows Arch. 440:476-484(2002)

PubMed=12966428; DOI=10.1038/sj.bjc.6601212; PMCID=PMC2376962
Li K.K.C., Goodall J., Goding C.R., Liao S.-K., Wang C.-H., Lin Y.-C., Hiraga H., Nojima T., Nagashima K., Schaefer K.-L., Lee K.A.W.
The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma.
Br. J. Cancer 89:1072-1078(2003)

PubMed=15150091; DOI=10.1158/0008-5472.CAN-03-0809
Schaefer K.-L., Brachwitz K., Wai D.H., Braun Y., Diallo R., Korsching E., Eisenacher M., Voss R., van Valen F., Baer C., Selle B., Spahn L., Liao S.-K., Lee K.A.W., Hogendoorn P.C.W., Reifenberger G., Gabbert H.E., Poremba C.
Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
Cancer Res. 64:3395-3405(2004)